These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30099750)

  • 61. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
    Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
    Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.
    Mutimer DJ; Fussey SP; Yeaman SJ; Kelly PJ; James OF; Bassendine MF
    Hepatology; 1989 Oct; 10(4):403-7. PubMed ID: 2673968
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [How to understand the clinical significance of autoantibodies in primary biliary cholangitis].
    Yan HP; Zhang HP; Chen XX
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):810-815. PubMed ID: 29325273
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis.
    Chen RC; Naiyanetr P; Shu SA; Wang J; Yang GX; Kenny TP; Guggenheim KC; Butler JD; Bowlus C; Tao MH; Kurth MJ; Ansari AA; Kaplan M; Coppel RL; Lleo A; Gershwin ME; Leung PS
    Hepatology; 2013 Apr; 57(4):1498-508. PubMed ID: 23184636
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression.
    Van Norstrand MD; Malinchoc M; Lindor KD; Therneau TM; Gershwin ME; Leung PS; Dickson ER; Homburger HA
    Hepatology; 1997 Jan; 25(1):6-11. PubMed ID: 8985257
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The immune response to mitochondrial autoantigens.
    Ishibashi H; Shimoda S; Gershwin ME
    Semin Liver Dis; 2005 Aug; 25(3):337-46. PubMed ID: 16143949
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up.
    Zandanell S; Strasser M; Feldman A; Tevini J; Strebinger G; Niederseer D; Pohla-Gubo G; Huber-Schönauer U; Ruhaltinger S; Paulweber B; Datz C; Felder TK; Aigner E
    J Intern Med; 2020 Apr; 287(4):395-404. PubMed ID: 31802567
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma.
    Kinoshita H; Omagari K; Whittingham S; Kato Y; Ishibashi H; Sugi K; Yano M; Kohno S; Nakanuma Y; Penner E; Wesierska-Gadek J; Reynoso-Paz S; Gershwin ME; Anderson J; Jois JA; Mackay IR
    Liver; 1999 Apr; 19(2):122-8. PubMed ID: 10220742
    [TBL] [Abstract][Full Text] [Related]  

  • 69. IgA class antibodies to 2-oxo-acid dehydrogenase complex are not predictive markers of histopathological progression in primary biliary cirrhosis.
    Omagari K; Kadokawa Y; Nakamura M; Akazawa S; Ohba K; Ohnita K; Mizuta Y; Daikoku M; Yatsuhashi H; Ishibashi H; Kohno S
    Autoimmunity; 2006 Mar; 39(2):107-12. PubMed ID: 16698666
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis.
    Syed H; Penner T; Mason AL
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146750
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.
    Surh CD; Ahmed-Ansari A; Gershwin ME
    J Immunol; 1990 Apr; 144(7):2647-52. PubMed ID: 1690773
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis.
    Shuai Z; Wang J; Badamagunta M; Choi J; Yang G; Zhang W; Kenny TP; Guggenheim K; Kurth MJ; Ansari AA; Voss J; Coppel RL; Invernizzi P; Leung PSC; Gershwin ME
    Hepatology; 2017 May; 65(5):1670-1682. PubMed ID: 28100006
    [TBL] [Abstract][Full Text] [Related]  

  • 73. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria.
    Butler P; Valle F; Hamilton-Miller JM; Brumfitt W; Baum H; Burroughs AK
    J Hepatol; 1993 Mar; 17(3):408-14. PubMed ID: 8315267
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detection of anti-branched chain 2-oxo acid dehydrogenase complex (BCOADC)-E2 antibody in primary biliary cirrhosis by ELISA using recombinant fusion protein.
    Miyakawa H; Abe K; Kitazawa E; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Kako M
    Autoimmunity; 1999; 30(1):11-20. PubMed ID: 10433090
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.
    Tsuneyama K; Van De Water J; Van Thiel D; Coppel R; Ruebner B; Nakanuma Y; Dickson ER; Gershwin ME
    Hepatology; 1995 Nov; 22(5):1440-6. PubMed ID: 7590661
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.
    Ambrosini YM; Yang GX; Zhang W; Tsuda M; Shu S; Tsuneyama K; Leung PS; Ansari AA; Coppel RL; Gershwin ME
    Clin Exp Immunol; 2011 Oct; 166(1):110-20. PubMed ID: 21910728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exploring pathogenesis of primary biliary cholangitis by proteomics: A pilot study.
    Deng CW; Wang L; Fei YY; Hu CJ; Yang YJ; Peng LY; Zeng XF; Zhang FC; Li YZ
    World J Gastroenterol; 2017 Dec; 23(48):8489-8499. PubMed ID: 29358857
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antimitochondrial Antibodies: from Bench to Bedside.
    Colapietro F; Lleo A; Generali E
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):166-177. PubMed ID: 34586589
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical impact of antibodies to Sp100 on a bacterial infection in patients with primary biliary cholangitis.
    Himoto T; Yamamoto S; Morimoto K; Tada S; Mimura S; Fujita K; Tani J; Morishita A; Masaki T
    J Clin Lab Anal; 2021 Nov; 35(11):e24040. PubMed ID: 34623692
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up.
    Zandanell S; Strasser M; Feldman A; Strebinger G; Aigner G; Niederseer D; Laimer M; Mussnig B; Paulweber B; Datz C; Aigner E
    Postgrad Med; 2021 Apr; 133(3):291-298. PubMed ID: 33538618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.